Meeting Report: The Fourth Annual PepTalk Meeting: The Human Proteome
Journal:
Current Proteomics
Volume:
2
Page:
83-86
Author(s):
Sean R. Gallagher
Anti-Angiogenic Therapy as a Cancer Treatment Paradigm
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
115-130
Author(s):
Mohanraj Dhanabal, Mike Jeffers and William J. LaRochelle
The Place of the Bioisosteric Sila-Substitution in Drug Design
Journal:
Drug Design Reviews - Online (Discontinued)
Volume:
2
Page:
467-483
Author(s):
Patrick Englebienne, Anne V. Hoonacker and C. V. Herst
Blocking the PI3K/PKB Pathway in Tumor Cells
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
449-462
Author(s):
F. Stauffer, P. Holzer and C. Garcia-Echeverria
Epidemiology of Psoriasis
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
3
Page:
121-128
Author(s):
Luigi Naldi
Targeting Tumor Necrosis Factor-α in the Therapy of Psoriasis
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
3
Page:
175-183
Author(s):
Paolo Gisondi, Emanuela Gubinelli, Barbara Cocuroccia and Giampiero Girolomoni
Photodynamic Therapy using Carbohydrate Conjugated Porphyrins
Journal:
Drug Design Reviews - Online (Discontinued)
Volume:
1
Page:
215-234
Author(s):
X. Chen and C. M. Drain
Pharmacoperones: A New Therapeutic Approach for Diseases Caused By Misfolded G Protein-Coupled Receptors
Journal:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume:
5
Page:
13-24
Author(s):
Alfredo Ulloa-Aguirre and P. Michael Conn
Subject Index to Volume 3
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
65-69
Author(s):
Bentham Science Publishers
Resveratrol and Cancer: Chemoprevention, Apoptosis, and Chemoimmunosensitizing Activities
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
77-93
Author(s):
C. Cal, H. Garban, A. Jazirehi, C. Yeh, Y. Mizutani and B. Bonavida